Popular
Finerenone in Patients With FSGS: A FIND-CKD Analysis
NephrologyFinerenone in Patients With FSGS: A FIND-CKD Analysis
prof. Hiddo Heerspink
Finerenone in Patients With IgAN: A FIND-CKD Analysis
NephrologyFinerenone in Patients With IgAN: A FIND-CKD Analysis
Brendon Neuen, MBBS, PhD
- CME/CE In-Person & Virtual Event
Choose Your Own Adventure: Navigating TED Care Across the Patient Journey
November 6, 2026
Philadelphia, Pennsylvania What Comes Next: Building the Future Lipid Toolbox
MinuteCE®What Comes Next: Building the Future Lipid Toolbox
Christie Ballantyne, MD
Erin Michos
Lipids and the Brain: Extending Cardiovascular Risk Reduction to Neurodegenerative Disease
MinuteCE®Lipids and the Brain: Extending Cardiovascular Risk Reduction to Neurodegenerative Disease
Christie Ballantyne, MD
Philip Scheltens, MD, PhD
The Unmet Need in ASCVD: Why Targets Are Still Not Enough
MinuteCE®The Unmet Need in ASCVD: Why Targets Are Still Not Enough
Erin Michos
Closing Research Gaps in Pulmonary Arterial Hypertension
Clinician's RoundtableClosing Research Gaps in Pulmonary Arterial Hypertension
John Kingrey, MD
How Classification Shapes Treatment in FSGS
Clinician's RoundtableHow Classification Shapes Treatment in FSGS
Abdallah Geara, MD
Green Tea Compound Shows Potential to Protect Podocytes in FSGS
Clinician's RoundtableGreen Tea Compound Shows Potential to Protect Podocytes in FSGS
Finerenone in IgAN: A Proteinuria Signal Worth Following
Clinician's RoundtableFinerenone in IgAN: A Proteinuria Signal Worth Following
TRIUMPH-2: Translating New Obesity Data Into Real-World Care
EndocrinologyTRIUMPH-2: Translating New Obesity Data Into Real-World Care
Elisabeth Van Rossum, MD, PhD
William Mencia, MD, FACEHP
Looking Beyond the Scale: Identifying the Drivers of Obesity
EndocrinologyLooking Beyond the Scale: Identifying the Drivers of Obesity
Elisabeth Van Rossum, MD, PhD
William Mencia, MD, FACEHP
Connecting the Dots in Obesity Care: Key Takeaways From EASD 2026
General Medicine and Primary CareConnecting the Dots in Obesity Care: Key Takeaways From EASD 2026
Elisabeth Van Rossum, MD, PhD
William Mencia, MD, FACEHP
EASD 2026: The Importance of Protecting Lean Muscle Mass in Managing Patients With Obesity
EndocrinologyEASD 2026: The Importance of Protecting Lean Muscle Mass in Managing Patients With Obesity
Stefan D. Anker, MD, PhD
EASD 2026: Changing the Set Point—A New Era in Obesity Management on the Horizon
Diabetes and EndocrinologyEASD 2026: Changing the Set Point—A New Era in Obesity Management on the Horizon
Carel le Roux, MBChB, MSC, FRCP, FRCPath, PhD
Clinical Practice
- Allergy and Clinical Immunology
- Anesthesiology
- Cardiology
- Clinical Pharmacology
- Cornea/External Disease
- Critical Care
- Dental
- Dermatology
- Diabetes and Endocrinology
- Emergency Medicine
- Endocrinology
- Gastroenterology and Hepatology
- General Medicine and Primary Care
- General Ophthalmology
- Genetics
- Geriatrics
- Glaucoma
- HIV/AIDS and Infectious Disease
- Hospice and Palliative Medicine
- Hospital Medicine
- Infectious Diseases
- Integrative Medicine
- Men's Health
- Musculoskeletal Disorders
- Nephrology
- Neurology and Neurosurgery
- Neuro-Ophthalmology
- Nutrition
- OB/GYN and Women's Health
- Ocular Immunology
- Ocular Oncology & Pathology
- Oculoplastic Surgery
- Oncology and Hematology
- Ophthalmology
- Optometry
- Orthopedics
- Otolaryngology
- Pain Management
- Pathology and Lab Medicine
- Pediatrics
- Pediatric Ophthalmology
- Podiatry
- Poisoning and Drug Reference
- Preventive Medicine
- Psychiatry and Mental Health
- Public Health
- Pulmonary Medicine
- Radiology
- Rare and Orphan Diseases
- Refractive Management
- Retina/Vitreous
- Rheumatology
- Sleep Medicine
- Sports Medicine
- Surgery
- Transplantation
- Urology
- Vascular Medicine